Mercer Global Advisors Inc Ocular Therapeutix, Inc Transaction History

Mercer Global Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 18, 2020	SELL	$3.95 - $7.4 $220,556 - $413,193	-55,837 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$2.57 - $4.73 $102,800 - $189,200	-40,000 Reduced 41.74%	55,837 $221,000
Q3 2019 Nov 12, 2019	BUY	$3.04 - $5.32 $30,400 - $53,200	10,000 Added 11.65%	95,837 $291,000
Q2 2019 Aug 14, 2019	SELL	$2.46 - $4.52 $12,300 - $22,599	-5,000 Reduced 5.5%	85,837 $378,000
Q1 2019 Apr 23, 2019	SELL	$3.51 - $4.77 $305 - $414	-87 Reduced 0.1%	90,837 $361,000
Q1 2019 Apr 12, 2019	BUY	$3.51 - $4.77 $319,143 - $433,707	90,924 New	90,924 $362,000

172

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $750M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.